CSI Market
Sign In | Register

Revolution Medicines Inc (RVMD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access RVMD Annual Cash Flow →
Quarterly cash flow trends provide additional context on Revolution Medicines Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1,098.19
Depreciation & amortization9.10
Amortization of Other Assets0.66
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation154.30
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction201.92
Gain Loss On Disposal Of Held For Sale Assets-
Operating Lease Right Of Use Asset Amortization-
Increase Decrease In Deferred Revenue Related Party-
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Operating Lease Liability-2.07
Increase Decrease In Other Prepaid And Noncurrent Assets0.38
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable21.89
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities39.04
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets59.32
Other Working Capital0.44
Other Noncash Income (Expense)0.00
Other net7.56
Payments for (Proceeds from) Other Operating Activities-137.51
Discontinued operations0.00
Net Cash flow from Operating Activities-741.48
Investing Activities
Capital Expenditures-3.82
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities-2,248.09
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities383.89
Proceeds From Sale Of Held For Sale Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net765.86
Discontinued operations0.00
Net Cash Flow from Investing Activities-1,486.06
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-5.00
Long-term debt - borrowings487.07
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1,692.70
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net484.46
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations388.60
Payments For Proceeds From Repurchases Of Early Exercised Stock-
Payments Of Deferred Offering Costs-0.25
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan-
Proceeds From Issuance Of Common Stock From At The Market Offering226.73
Cash And Cash Equivalents And Restricted Cash Acquired In Connection With Eqrx Acquisition Net Of Transaction Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2,659.23
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-745.31
Total Cash Flow431.69
4 historic quarters locked

Sign in to unlock the full Revolution Medicines Inc cash flow history.

Sign In Create Free Account

About Revolution Medicines Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-335104

Figures are derived from filed reports and may be restated. Historical data is subject to revision.